SCHEMBL3245374

SCHEMBL3245374

CCOc1cc(Cc2cccc(Cl)c2F)cc2c(=O)c(OC(=O)O)cn([C@H](CO)C3CCCCC3)c12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 1/20 0.41
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PYGL P06737 2/20 0.31
THRB P10828 1/20 0.31
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CFD P00746 1/20 0.31
ENPP2 Q13822 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
CD274 Q9NZQ7 1/20 0.30
HTR2C P28335 1/20 0.30
SLC6A4 P31645 1/20 0.30
P2RX7 Q99572 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
OPRK1 P41145 1/20 0.30
EGFR P00533 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3243386 0.94 METTL3 (0.46) METTL3PYGLCFDRXFP1EGFR
SCHEMBL3242029 0.92 METTL3 (0.43) METTL3PYGLCFDRXFP1P2RX7
SCHEMBL1046596 0.92 METTL3 (0.50) METTL3KMT2AMEN1SMN1; SMN2PYGL
SCHEMBL3243285 0.92 METTL3 (0.50) METTL3KMT2AMEN1SMN1; SMN2PYGL
SCHEMBL3239627 0.86 METTL3 (0.47) METTL3KMT2AMEN1THRBMAPT
SCHEMBL3246669 0.86 METTL3 (0.54) METTL3CFDRXFP1CD274HTR2C
SCHEMBL3241758 0.86 METTL3 (0.43) METTL3THRBRXFP1CD274ALDH1A1
SCHEMBL1041873 0.85 METTL3 (0.56) METTL3PYGLCFD
SCHEMBL1041874 0.85 METTL3 (0.56) METTL3PYGLCFD
SCHEMBL3235235 0.85 METTL3 (0.53) METTL3THRBCFDRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1564210-B9 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS JAPAN TOBACCO INC (JP) 2010-03-31 EP claimed
EP-1564210-B1 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS JAPAN TOBACCO INC (JP) 2009-09-16 EP claimed